Monika Lewinska, Ph.D.
@LewinskaMonika
Researching metabolic stress, liver diseases and cancer metabolism at BRIC, University of Copenhagen, Denmark.
ID:1192366900409511936
07-11-2019 09:03:31
561 Tweets
261 Followers
629 Following
FDA approved trastuzumab deruxtecan for previously treated unresectable or metastatic HER2-positive solid cancers
👉first tumor-agnostic approval for antibody-drug conjugate targeting HER2-positive tumors
👉More options for many GI-cancers, incl. CRC & BTC
ESMO - Eur. Oncology Cholangiocarcinoma Foundation…
Huge congratulations to Dr. Bichitra Paul for a successful defence! 👏 linkedin.com/posts/bichitra…
Typical #LiverCancerSummit dinner wherever we are we are together Maria Reig Sherrie Bhoori Marco Sanduzzi Zamparelli Gonzalo Sapisochin Ana Lleo Arndt Vogel Jean-Charles Nault Anna Saborowski Valerie Chew Julien Calderaro Ciro Celsa EASL Education
Robert Schwabe presents 'The fibrogenic stroma in HCC and CCA' at #LiverCancerSummit 2024.
- For HCC, thinking about fibroblasts is more of a prevention strategy, by turning disease-promoting fibroblasts to protective fibroblasts.
- For ICC, thinking about targeting fibroblasts…
Hot discussion on liver transplantation in #iCCA patients
Cholangiocarcinoma Foundation EURO-CHOLANGIO-NET Global Cholangiocarcinoma Alliance
🌅 Ola delegates!
The day is here! #ILTSILCA2024 kicks off today. We're diving into cutting-edge discussions on #LiverTransplantation for HCC and iCCA.
Let's make this an unforgettable experience! 🌐👨⚕️
@ilcanews
#MedicalInnovation #ExcitementBuilds #DayOne
New paper out describing the role of #Fibroblast -derived lysyl oxidase increases oxidative phosphorylation and stemness in #cholangiocarcinoma Gastroenterology by Monika Lewinska, Ph.D. AndersenLab. To collaborators 🙏. EASLnews gastrojournal.org/article/S0016-…
🚀Takeoff of Precision-BTC-Network
Happy to coordinate with chiara braconi an interdisciplinary network to promote personalized approaches for patients with biliary cancer
👩🏽🔬🧑🔬>40 countries
EASLnews ILCA my_UEG
AMMF Cholangiocarcinoma Foundation
Apply to join: cost.eu/actions/CA2212…
After 7 years at AndersenLab it was time to say goodbye as I am starting a new scientific journey at Gubra. Many thanks to all my colleagues who made the last 7 years memorable. Juan LB Yuewan Luo Bichitra Paul Yangngam S (Mai) Marvelmario Gabriel ASAP_BRIC Biotech Research & Innovation Centre (BRIC)